Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 333 followers
Latest posts
Last updated about 1 hour ago
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2026
about 1 hour ago
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)...
Human medicines European public assessment report (EPAR): Azacitidine Adienne, azacitidine, Status: Application withdrawn
about 1 hour ago
Human medicines European public assessment report (EPAR): Azacitidine Adienne, azacitidine, Status: Application...
Human medicines European public assessment report (EPAR): Susvimo, ranibizumab, Status: Opinion
about 1 hour ago
Human medicines European public assessment report (EPAR): Susvimo, ranibizumab, Status: Opinion
Human medicines European public assessment report (EPAR): Zokovea, ensitrelvir, Status: Opinion
about 1 hour ago
Human medicines European public assessment report (EPAR): Zokovea, ensitrelvir, Status: Opinion
First oral medicine targeting interleukin-23 receptor recommended for plaque psoriasis
about 1 hour ago
First oral medicine targeting interleukin-23 receptor recommended for plaque psoriasis
New treatment option for neovascular age-related macular degeneration
about 1 hour ago
New treatment option for neovascular age-related macular degeneration
Human medicines European public assessment report (EPAR): Riociguat Accord, riociguat, Status: Opinion
4 days ago
Human medicines European public assessment report (EPAR): Riociguat Accord, riociguat, Status: Opinion
Human medicines European public assessment report (EPAR): Ruxolitinib Viatris, ruxolitinib hemifumarate, Status: Opinion
4 days ago
Human medicines European public assessment report (EPAR): Ruxolitinib Viatris, ruxolitinib hemifumarate, Status...
Human medicines European public assessment report (EPAR): Tafamidis Accord, tafamidis, Status: Opinion
4 days ago
Human medicines European public assessment report (EPAR): Tafamidis Accord, tafamidis, Status: Opinion
Summary of opinion: Trodelvy, 23/07/2026 Positive
1 day ago
Summary of opinion: Trodelvy, 23/07/2026 Positive
Human medicines European public assessment report (EPAR): Evlarco, obicetrapib,ezetimibe, Status: Opinion
about 1 hour ago
Human medicines European public assessment report (EPAR): Evlarco, obicetrapib,ezetimibe, Status: Opinion